Insider · CIK 0002009368
Elaine Mary Shannon
Files at TAK (TAKEDA PHARMACEUTICAL CO LTD). First filing Aug 12, 2026, latest Aug 12, 2026.
In brief
Elaine Mary Shannon files SEC Form 4 as officer at TAK (TAKEDA PHARMACEUTICAL CO LTD). Since Aug 12, 2026, Elaine Mary Shannon has reported 0 open-market buys worth $0 and 2 open-market sells worth $425k, the latest filed on Aug 12, 2026.
A track record needs three past buys with six months of prices behind them; Elaine Mary Shannon has 0, so none is measured yet.
The newest scored trade: sold $357k of TAK on Aug 11, 2026, filed Aug 12, 2026, scored 50 (moderate). In the last 12 months: 0 buys worth $0 and 2 sells worth $425k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
TAK: TAKEDA PHARMACEUTICAL CO LTD
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 50Moderate | TAKEDA PHARMACEUTICAL CO LTD | $357k 20,363 shares | -23% | +32% from low-7% from high | |
| 38Weak | TAKEDA PHARMACEUTICAL CO LTD | $68k 3,978 shares | -6% | +33% from low-7% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Aug 10, 2026 | TAK Takeda Pharmaceutical Company Limited | 20,363 0.01% of outstanding | $355k | Aug 11, 2026 | $72k |
| Jul 13, 2026 | TAK Takeda Pharmaceutical Company Limited | 4,319 0.00% of outstanding | $72k | Jul 13, 2026 | none |
| Jul 9, 2025 | TAK Takeda Pharmaceutical Company Limited | 4,477 0.00% of outstanding | $69k | Jul 9, 2025 | none |
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 11, 2026 | TAK TAKEDA PHARMACEUTICAL CO LTD | SOpen-market sale American Depositary Shares | -20,363 | $17.55 | $357k | 67,311 | Aug 12, 2026 |
| Aug 10, 2026 | TAK TAKEDA PHARMACEUTICAL CO LTD | SOpen-market sale American Depositary Shares | -3,978 | $17.10 | $68k | 63,333 | Aug 12, 2026 |
| Jul 1, 2026 | TAK TAKEDA PHARMACEUTICAL CO LTD | AGrant or award American Depositary Shares | +30,094 | $0.00 | $0 | 87,674 | Jul 6, 2026 |
Questions about Elaine Mary Shannon
Answered from the filings on this page, as of the latest one.
Is Elaine Mary Shannon buying or selling?
In the last 12 months Elaine Mary Shannon reported 0 open-market buys worth $0 and 2 open-market sells worth $425k on SEC Form 4; the latest was sold $357k of TAK on Aug 11, 2026. Grants, option exercises and tax withholding are not counted.
How did Elaine Mary Shannon's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Elaine Mary Shannon has 0.
Where does Elaine Mary Shannon file Form 4?
Elaine Mary Shannon has filed Form 4 at TAK (TAKEDA PHARMACEUTICAL CO LTD) as Pres., Global Supply & Quality. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.